table_specific

Which section of the Learningrx Developer Agreement discusses transfer obligations, as referenced in Item 17 of the Disclosure Document?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

Section in Area Item in Disclosure
Obligation
Developer Agreement Document
q. Owner’s participation/management staffing Not applicable Not applicable
r. Records/reports Section 4.03 Not applicable
s. Inspection/audits Not applicable 11
t. Transfer Section 7 17
u. Renewal Section 2 17
v. Post-termination obligations Section 9.02 17
w. Non-competition covenants Section 9 17
x. Dispute resolution Section 10 17
y. Other: Guaranty Section 7.04 and 15

Source: Item 11 — FRANCHISOR'S ASSISTANCE, ADVERTISING, COMPUTER SYSTEM, AND TRAINING (FDD pages 26–33)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, Item 11 outlines various obligations and their corresponding sections within the Area Developer Agreement and Item in the Disclosure Document. Specifically, the section in the Area Developer Agreement that addresses transfer obligations is Section 7. This is directly related to Item 17 of the Disclosure Document, which generally covers transfer, renewal, post-termination, non-competition, and dispute resolution obligations.

For a prospective Learningrx Area Developer, this means that Section 7 of the Area Developer Agreement will contain the specific details and requirements regarding the transfer of the development rights or responsibilities. Understanding this section is crucial for anyone considering selling their rights to another party or taking over an existing development territory.

It is important for potential franchisees to carefully review Section 7 to understand the conditions under which a transfer is permissible, any fees associated with the transfer, the franchisor's approval process, and any other obligations that must be met by both the transferring and receiving parties. This knowledge will help ensure compliance with the agreement and avoid potential disputes or penalties.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.